GeneLink, Inc.
GNLKQ
$0.00
$0.000.00%
| 09/30/2013 | 06/30/2013 | 03/31/2013 | 12/31/2012 | 09/30/2012 | |
|---|---|---|---|---|---|
| Revenue | 294.70K | 621.90K | 399.90K | 412.50K | 425.10K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 294.70K | 621.90K | 399.90K | 412.50K | 425.10K |
| Cost of Revenue | 222.20K | 312.90K | 307.50K | 429.90K | 514.80K |
| Gross Profit | 72.50K | 309.00K | 92.40K | -17.40K | -89.70K |
| SG&A Expenses | 635.50K | 511.30K | 420.70K | 716.90K | 723.70K |
| Depreciation & Amortization | 12.90K | 13.20K | 14.60K | 16.30K | 6.40K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 898.10K | 862.20K | 757.30K | 1.26M | 1.32M |
| Operating Income | -603.30K | -240.30K | -357.40K | -851.20K | -892.00K |
| Income Before Tax | -539.30K | -325.10K | -353.80K | -1.01M | -974.40K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -539.30K | -325.10K | -353.80K | -1.01M | -974.40K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -539.30K | -325.10K | -353.80K | -1.01M | -974.40K |
| EBIT | -603.30K | -240.30K | -357.40K | -851.20K | -892.00K |
| EBITDA | -584.30K | -219.90K | -333.00K | -818.50K | -869.40K |
| EPS Basic | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 263.35M | 257.80M | 253.35M | 249.49M | 207.72M |
| Average Diluted Shares Outstanding | 263.35M | 257.80M | 253.35M | 249.49M | 207.72M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
